These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 9869111)
1. DNA vaccines: application to tuberculosis. Huygen K Int J Tuberc Lung Dis; 1998 Dec; 2(12):971-8. PubMed ID: 9869111 [TBL] [Abstract][Full Text] [Related]
2. [Advance in DNA vaccine against Mycobacterium tuberculosis]. Wang BL; Wang HH Zhonghua Jie He He Hu Xi Za Zhi; 2004 Nov; 27(11):787-90. PubMed ID: 15634398 [No Abstract] [Full Text] [Related]
3. A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice. Liu S; Gong Q; Wang C; Liu H; Wang Y; Guo S; Wang W; Liu J; Shao M; Chi L; Zhao K; Wang Z; Shi Y; Huang Y; Guli A; Zhang C; Kong X Immunol Lett; 2008 May; 117(2):136-45. PubMed ID: 18339431 [TBL] [Abstract][Full Text] [Related]
4. Immune response and protection by DNA vaccines expressing antigen 85B of Mycobacterium tuberculosis. Pardini M; Giannoni F; Palma C; Iona E; Cafaro A; Brunori L; Rinaldi M; Fazio VM; Laguardia ME; Carbonella DC; Magnani M; Ensoli B; Fattorini L; Cassone A FEMS Microbiol Lett; 2006 Sep; 262(2):210-5. PubMed ID: 16923077 [TBL] [Abstract][Full Text] [Related]
5. CD8+ T lymphocytes against mycobacterium tuberculosis. Klein MR; McAdam KP Arch Immunol Ther Exp (Warsz); 1999; 47(5):313-20. PubMed ID: 10604237 [TBL] [Abstract][Full Text] [Related]
6. The potential use of heat-shock proteins to vaccinate against mycobacterial infections. Silva CL Microbes Infect; 1999 May; 1(6):429-35. PubMed ID: 10602675 [TBL] [Abstract][Full Text] [Related]
7. Rational design of novel antibacterial vaccines with an emphasis on tuberculosis. Kaufmann SH Scand J Infect Dis; 2008; 40(8):595-600. PubMed ID: 18979596 [TBL] [Abstract][Full Text] [Related]
8. DNA vaccines against mycobacterial diseases. Romano M; Huygen K Expert Rev Vaccines; 2009 Sep; 8(9):1237-50. PubMed ID: 19722896 [TBL] [Abstract][Full Text] [Related]
9. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection. Wozniak TM; Ryan AA; Triccas JA; Britton WJ Infect Immun; 2006 Jan; 74(1):557-65. PubMed ID: 16369012 [TBL] [Abstract][Full Text] [Related]
10. Differential immunogenicity and protective efficacy of DNA vaccines expressing proteins of Mycobacterium tuberculosis in a mouse model. Fan X; Gao Q; Fu R Microbiol Res; 2009; 164(4):374-82. PubMed ID: 17764918 [TBL] [Abstract][Full Text] [Related]
11. MPT-51/CpG DNA vaccine protects mice against Mycobacterium tuberculosis. Silva BD; da Silva EB; do Nascimento IP; Dos Reis MC; Kipnis A; Junqueira-Kipnis AP Vaccine; 2009 Jul; 27(33):4402-7. PubMed ID: 19500525 [TBL] [Abstract][Full Text] [Related]
12. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of Ag85B and MPT64 DNA vaccines in a murine model of Mycobacterium tuberculosis infection. Zhu D; Jiang S; Luo X Vaccine; 2005 Aug; 23(37):4619-24. PubMed ID: 16053938 [TBL] [Abstract][Full Text] [Related]
14. Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis. Feng CG; Palendira U; Demangel C; Spratt JM; Malin AS; Britton WJ Infect Immun; 2001 Jun; 69(6):4174-6. PubMed ID: 11349095 [TBL] [Abstract][Full Text] [Related]
15. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv. Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518 [TBL] [Abstract][Full Text] [Related]
16. Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice. Xu J; Xu W; Chen X; Zhao D; Wang Y Vaccine; 2008 Aug; 26(35):4519-25. PubMed ID: 18598729 [TBL] [Abstract][Full Text] [Related]
17. Therapy of tuberculosis in mice by DNA vaccination. Lowrie DB; Tascon RE; Bonato VL; Lima VM; Faccioli LH; Stavropoulos E; Colston MJ; Hewinson RG; Moelling K; Silva CL Nature; 1999 Jul; 400(6741):269-71. PubMed ID: 10421369 [TBL] [Abstract][Full Text] [Related]
18. Intranasal delivery of DNA encoding antigens of Mycobacterium tuberculosis by non-pathogenic invasive Escherichia coli. Brun P; Zumbo A; Castagliuolo I; Delogu G; Manfrin F; Sali M; Fadda G; Grillot-Courvalin C; Palù G; Manganelli R Vaccine; 2008 Apr; 26(16):1934-41. PubMed ID: 18342411 [TBL] [Abstract][Full Text] [Related]
19. [Search for new tuberculosis vaccines]. Gicquel B Bull Acad Natl Med; 1999; 183(7):53-61; discussion 61-2. PubMed ID: 10622122 [TBL] [Abstract][Full Text] [Related]
20. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice. Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L; Cassone A Cell Microbiol; 2007 Jun; 9(6):1455-65. PubMed ID: 17250590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]